Pluristem Therapeutics (Nasdaq: PSTI) 36.5% HIGHER; this stem cell-related company is trading higher today on reports out of Northwestern University that researchers may have “reversed the neurological dysfunction of early-stage multiple sclerosis patients by transplanting their own immune stem cells into their bodies and thereby “resetting” their immune systems”, according to a piece in the ScienceDaily. The stock is up about 185% during the last 4 trading sessions following reports from Geron (Nasdaq: GERN) and news that Pluristem has collaborated with several German hospitals.

NOVA Chemicals (NYSE: NCX) 36% LOWER; continuing lower today following Q4 earnings